ARDX · Healthcare · $845M
$3.42+0.88%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출 1억1800만 달러로 전년 대비 31% 늘며 역대 최대치를 냈어요.”
In the company's words · 2026 2분기 earnings call